Isavuconazole prophylaxis in patients with hematologic malignancies and hematopoietic cell transplant recipients

Keyphrases

• Hematological Malignancies 100%
• Haematopoietic Stem Cell Transplant Recipients 100%
• Isavuconazole 100%
• Breakthrough Invasive Fungal Infections 58%
• Primary Prophylaxis 33%
• Voriconazole 25%
• Posaconazole 25%
• Invasive Pulmonary Aspergillosis 16%
• Clinical High Risk 8%
• Retrospective Review 8%
• Relapsed or Refractory Acute Myeloid Leukemia 8%
• Fusarium Species 8%
• Neutropenia 8%
• Invasive mucormycosis 8%
• Aspergillus Fumigatus 8%
• Candida Glabrata 8%
• Aspergillus Species 8%
• Patient Cells 8%
• Invasive Aspergillus 8%
• Mucorales 8%
• Relapsed or Refractory 8%

Immunology and Microbiology

• Transplant Procedure 100%
• Hematopoietic Cell 100%
• Aspergillus 66%
• Mould 33%
• Candida Glabrata 33%
• Fusarium 33%
• Myeloid 33%
• Aspergillus fumigatus 33%
• Mucorales 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Isavuconazole 100%
• Hematologic Malignancy 100%
• Systemic Mycosis 58%
• Voriconazole 25%
• Posaconazole 25%
• Invasive Aspergillosis 16%
• Aspergillus 16%
• Aspergillus fumigatus 8%
• Fusarium 8%
• Mucorales 8%
• Mould 8%
• Acute Myeloid Leukemia 8%
• Neutropenia 8%
• Candida Glabrata 8%
• Mucormycosis 8%